Humacyte
HUMA
HUMA
88 hedge funds and large institutions have $51.1M invested in Humacyte in 2023 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 35 increasing their positions, 17 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
5% more capital invested
Capital invested by funds: $48.7M → $51.1M (+$2.42M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
78% less call options, than puts
Call options by funds: $104K | Put options by funds: $480K
Holders
88
Holding in Top 10
1
Calls
$104K
Puts
$480K
Top Buyers
1 | +$1.13M | |
2 | +$651K | |
3 | +$611K | |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$296K |
5 |
Geode Capital Management
Boston,
Massachusetts
|
+$274K |
Top Sellers
1 | -$587K | |
2 | -$265K | |
3 | -$250K | |
4 |
KA
Kovack Advisors
Ft. Lauderdale,
Florida
|
-$123K |
5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$115K |